Combining Cell Culture Analogue Reactor Designs and PBPK Models to Probe Mechanisms of Naphthalene Toxicity

An alternative method of evaluating the toxicology of a chemical is to use cultured mammalian cells in a novel cell culture analogue reactor (CCA) together with a corresponding physiologically based pharmacokinetic model (PBPK). The PBPK is a mathematical model that divides the body into compartments representing organs, integrating the kinetic, thermodynamic, and anatomical parameters of the animal. The bioreactor is a physical replica of the PBPK; where the PBPK specifies an organ or tissue compartment, the bioreactor contains compartments with a corresponding cell type. The device is a continuous, dynamic system composed of multiple cell types that interact through a common circulating cell culture medium. The bioreactor and the model are coupled to evaluate the plausibility of the molecular mechanism that is input into the model. This concept is tested with naphthalene as a model of PAH (polycyclic aromatic hydrocarbons) toxicants. Two physically different CCA reactors were tested with naphthalene, and different results were observed. In the prototype system using cells attached to glass dilution bottles, naphthalene dosing resulted in generation of a circulating metabolite from the “liver” compartment (based on H4IIE cells from a rat hepatoma) that caused cell death in the “lung” compartment (L2 cells from a rat lung), as well as depletion of glutathione in the L2 cells. An improved CCA using packed bed reactors of microcarrier cultured cells did not show differences between naphthalene‐dosed and nondosed controls. To explain the different responses of the two CCA designs, PBPKs of the two reactors were tested with variations in physical and kinetic parameters, and toxic mechanism. When the toxic metabolite of naphthalene was naphthoquinone rather than naphthalene epoxide as initially assumed, the PBPK results were consistent with the results of the two CCA designs. This result indicates that the mechanism of naphthalene toxicity in the CCAs may be mediated through naphthoquinone formation. The CCA‐PBPK concept is demonstrated to be applicable to the study of toxic mechanisms. In particular, use of this approach suggests that in vitro naphthalene toxicity is mediated through the naphthoquinone metabolite.

[1]  J. Sedlák,et al.  Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. , 1968, Analytical biochemistry.

[2]  B D Hammock,et al.  Evidence of quinone metabolites of naphthalene covalently bound to sulfur nucleophiles of proteins of murine Clara cells after exposure to naphthalene. , 1997, Chemical research in toxicology.

[3]  N. Kalogerakis,et al.  Development of the optimal inoculation conditions for microcarrier cultures , 1992, Biotechnology and bioengineering.

[4]  J. Tosk,et al.  Formation and determination of naphthalenes in cigarette smoke. , 1976, Analytical chemistry.

[5]  M Pirmohamed,et al.  Characterisation of the toxic metabolite(s) of naphthalene. , 1996, Toxicology.

[6]  E. Bresnick,et al.  Induction of cytochrome P450IA1 and its recombinant construct in H4IIE rat hepatoma cells. , 1993, The International journal of biochemistry.

[7]  M L Shuler,et al.  Use of In Vitro Data for Construction of a Physiologically Based Pharmacokinetic Model for Naphthalene in Rats and Mice To Probe Species Differences , 1999, Biotechnology progress.

[8]  C. Plopper,et al.  Metabolism and cytotoxicity of naphthalene and its metabolites in isolated murine Clara cells. , 1994, Molecular pharmacology.

[9]  L M Sweeney,et al.  A cell culture analogue of rodent physiology: Application to naphthalene toxicology. , 1995, Toxicology in vitro : an international journal published in association with BIBRA.

[10]  M L Shuler,et al.  A self-regulating cell culture analog device to mimic animal and human toxicological responses. , 1996, Biotechnology and bioengineering.

[11]  D. Brown,et al.  Evidence for cytochrome P-450 mediated metabolism in the bronchiolar damage by naphthalene. , 1982, Chemico-biological interactions.

[12]  W. Bradshaw,et al.  Developmental toxicity of nine selected compounds following prenatal exposure in the mouse: naphthalene, p-nitrophenol, sodium selenite, dimethyl phthalate, ethylenethiourea, and four glycol ether derivatives. , 1985, Journal of toxicology and environmental health.

[13]  M L Shuler,et al.  Characterization of a Perfusion Reactor Utilizing Mammalian Cells on Microcarrier Beads , 2000, Biotechnology progress.

[14]  H. Vainio,et al.  Monoclonal antibody-directed characterization of benzene, ethoxyresorufin and pentoxyresorufin metabolism in rat liver microsomes. , 1990, Biochemical pharmacology.

[15]  G. Shopp,et al.  Naphthalene toxicity in CD-1 mice: general toxicology and immunotoxicology. , 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[16]  R. Mayer,et al.  Ethoxyresorufin: direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene. , 1974, Drug metabolism and disposition: the biological fate of chemicals.

[17]  J M Frazier,et al.  Alternatives to animals in toxicity testing. , 1989, Scientific American.

[18]  R. Franklin,et al.  Relationship of naphthalene and 2-methylnaphthalene metabolism to pulmonary bronchiolar epithelial cell necrosis. , 1989, Pharmacology & therapeutics.